Indacaterol

Chemical formula: C₂₄H₂₈N₂O₃  Molecular mass: 392.491 g/mol  PubChem compound: 6918554

Therapeutic indications

Indacaterol is indicated for:

Chronic obstructive pulmonary disease (COPD)

Population group: only adults (18 years old or older)

Indacaterol is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Indacaterol is contraindicated in the following cases:

Lactation

Lactation

Asthma

Airway hyperreactivity

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: ONBREZ BREEZHALER Inhalation powder, hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈